Bayer AG
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
Bayer AG has 195 disclosed EU lobbying meetings from 2020-04-07 to 2026-10-14: 90 with the European Commission and 105 with Members of the European Parliament. Source: EU Transparency Register no. 3523776801-85, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2026-02-05- Category
- Companies & groups
- Legal status
- Company / Aktiengesellschaft
- Declared lobbying cost
- €6,000,000
- Lobbying FTEs
- 20
- Members
- 10
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Agriculture and rural development · Banking and financial services · Business and industry · Climate action · Competition · Consumers · Customs · Digital economy and society · Economy, finance and the euro · Energy · Environment · Food safety
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
- Olivér Várhelyi8
- Flavio Facioni4
- Jana Dabbelt3
- Antonella Rossetti3
- Wopke Hoekstra3
Disclosed meetings
Newest first, showing the most recent 60 of 195. EC = European Commission, EP = Member of the European Parliament.
- 2026-10-14ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiEU-Mexico health cooperationsource ↗
- 2026-10-02ECVilija Sysaite · Cabinet of Executive Vice-President Stéphane SéjournéPharmaceuticals, Biotech Act II, PFASsource ↗
- 2026-09-30ECPeter Sandler · DirectorEconomic securitysource ↗
- IORP IIsource ↗
- Food & Feed Omnibussource ↗
- Food & Feedsource ↗
- Food & Feed Omnibussource ↗
- Austausch zum Food and Feed Omnibussource ↗
- 2026-07-03ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiLife Sciences Roundtablesource ↗
- 2026-06-22ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiPharmaceuticalssource ↗
- Novel foodsource ↗
- Plant Healthsource ↗
- 2026-06-09ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiBiotech incubatorsource ↗
- 2026-06-09ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiBiotech incubatorsource ↗
- 2026-06-05ECIoan-Dragos Tudorache · Cabinet of Executive Vice-President Stéphane SéjournéEU competitiveness agendasource ↗
- Women's healthsource ↗
- 2026-05-28ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- 2026-05-28ECFlavio Facioni · Cabinet of Commissioner Olivér VárhelyiChallenges and priorities for health and life sciencessource ↗
- Austauschsource ↗
- NGTssource ↗
- Biotech Actsource ↗
- NGTsource ↗
- Chemical Omnibussource ↗
- New Genomic Techniquessource ↗
- NGTssource ↗
- NGT policysource ↗
- 2026-05-05ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiBiotech Actsource ↗
- 2026-05-05ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiBiotech Actsource ↗
- Competitive Europe Salon Dinnersource ↗
- EU Biotech Act Isource ↗
- NGTssource ↗
- Environmental Omnibussource ↗
- 2026-04-19ECValdis Dombrovskis · Cabinet of Commissioner Valdis DombrovskisSimplification and competitivenesssource ↗
- 2026-04-16ECAdam Romanowski · Cabinet of Commissioner Maroš ŠefčovičEU-Chinese relations; Food & Feed Safety Omnibussource ↗
- GMMsource ↗
- Food and feed safety onlinesource ↗
- Omnibus Food and Feedsource ↗
- Challenges and Policy Goals in Health Caresource ↗
- Biotech actsource ↗
- 2026-03-04ECAntonella Rossetti · Cabinet of Commissioner Christophe HansenFood and Feed Omnibus – implications for the seed sectorsource ↗
- 2026-03-04ECPatricia Reilly · Cabinet of President Ursula von der LeyenExchange on strategic initiatives shaping innovation and competitiveness in the life sciencessource ↗
- Life science industry's connection to competitiveness and growthsource ↗
- Pharmaceutical industrysource ↗
- Health Policysource ↗
- Health Policysource ↗
- Current Topics related to Plant Protection (PFAS, biofuels)source ↗
- 2026-03-03ECAntti Timonen · Cabinet of Executive Vice-President Henna VirkkunenDiscussion on the outlook of the competitiveness of the life sciences sectorsource ↗
- 2026-03-03ECAnniina Iskanius · Cabinet of Executive Vice-President Henna VirkkunenDiscussion on the outlook of the competitiveness of the life sciences sectorsource ↗
- Food n Feedsource ↗
- Chemicals and environmentsource ↗
- Food n Feed Safetysource ↗
- Food and Feed Omnibussource ↗
- Geopolitical Situation in Europe and Defensesource ↗
- 2026-02-13ECWopke Hoekstra · Cabinet of Commissioner Wopke HoekstraRelation EU-US Economic status EU and Germanysource ↗
- 2026-02-13ECJan Ceyssens · Cabinet of Commissioner Jessika RoswallPresentation of Bayersource ↗
- 2026-02-13ECJessika Roswall · Cabinet of Commissioner Jessika RoswallPresentation of Bayersource ↗
- 2026-02-13ECMyriam Jans · Cabinet of Commissioner Wopke HoekstraRelation EU-US Economic status EU and Germanysource ↗
- Politischer Austauschsource ↗
- Critical Raw Materialssource ↗
- 2026-02-03ECCarmen Laplaza Santos · Head of UnitExchange of views on the competitiveness of the European pharmaceutical sector.source ↗
Frequently asked
How many EU lobbying meetings has Bayer AG disclosed?
Bayer AG (EU Transparency Register no. 3523776801-85) appears in 195 disclosed meetings with EU officials and MEPs between 2020-04-07 and 2026-10-14: 90 with the European Commission and 105 with Members of the European Parliament.
What does Bayer AG lobby on?
Bayer AG's disclosed EU meetings most often concern Technology, Health, Agriculture, Climate. Every meeting and its topic is listed with its official source on this page.
Who does Bayer AG meet in Brussels?
Across its disclosed meetings, Bayer AG has met Commission officials including Olivér Várhelyi, Flavio Facioni, Jana Dabbelt, and MEPs including LINS Norbert, POLFJÄRD Jessica, MARAN Pierfrancesco. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with Bayer AG — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.